Pfohl, U.; Loskutov, J.; Bashir, S.; KĂĽhn, R.; Herter, P.; Templin, M.; Mamlouk, S.; Belanov, S.; Linnebacher, M.; BĂĽrtin, F.;
et al. A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer. Cancers 2022, 14, 3252.
https://doi.org/10.3390/cancers14133252
AMA Style
Pfohl U, Loskutov J, Bashir S, KĂĽhn R, Herter P, Templin M, Mamlouk S, Belanov S, Linnebacher M, BĂĽrtin F,
et al. A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer. Cancers. 2022; 14(13):3252.
https://doi.org/10.3390/cancers14133252
Chicago/Turabian Style
Pfohl, Ulrike, JĂĽrgen Loskutov, Sanum Bashir, Ralf KĂĽhn, Patrick Herter, Markus Templin, Soulafa Mamlouk, Sergei Belanov, Michael Linnebacher, Florian BĂĽrtin,
and et al. 2022. "A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer" Cancers 14, no. 13: 3252.
https://doi.org/10.3390/cancers14133252
APA Style
Pfohl, U., Loskutov, J., Bashir, S., KĂĽhn, R., Herter, P., Templin, M., Mamlouk, S., Belanov, S., Linnebacher, M., BĂĽrtin, F., Vetter, M., Reinhard, C., Wedeken, L., & Regenbrecht, C. R. A.
(2022). A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer. Cancers, 14(13), 3252.
https://doi.org/10.3390/cancers14133252